Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Irritable Bowel Syndrome | 34 | 2024 | 455 | 8.220 |
Why?
|
| Constipation | 25 | 2023 | 562 | 4.890 |
Why?
|
| Diarrhea | 22 | 2024 | 1319 | 3.680 |
Why?
|
| Dyspepsia | 5 | 2023 | 116 | 1.890 |
Why?
|
| Gastrointestinal Diseases | 7 | 2024 | 1197 | 1.740 |
Why?
|
| Diverticulitis | 4 | 2024 | 185 | 1.630 |
Why?
|
| Diverticulitis, Colonic | 2 | 2024 | 138 | 1.450 |
Why?
|
| Antidiarrheals | 2 | 2019 | 46 | 1.190 |
Why?
|
| Gastrointestinal Agents | 5 | 2021 | 510 | 1.140 |
Why?
|
| Defecation | 6 | 2020 | 190 | 1.070 |
Why?
|
| Laxatives | 3 | 2023 | 92 | 1.010 |
Why?
|
| Plant Oils | 4 | 2022 | 198 | 0.960 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2022 | 431 | 0.800 |
Why?
|
| Postprandial Period | 1 | 2024 | 315 | 0.800 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2019 | 93 | 0.770 |
Why?
|
| Abdominal Pain | 9 | 2023 | 1069 | 0.770 |
Why?
|
| Marfan Syndrome | 2 | 2019 | 236 | 0.720 |
Why?
|
| Methane | 1 | 2020 | 51 | 0.700 |
Why?
|
| Gastroparesis | 2 | 2019 | 136 | 0.700 |
Why?
|
| Proanthocyanidins | 1 | 2019 | 20 | 0.690 |
Why?
|
| Dizziness | 1 | 2022 | 259 | 0.680 |
Why?
|
| Vomiting | 3 | 2023 | 652 | 0.640 |
Why?
|
| Placebo Effect | 2 | 2019 | 518 | 0.610 |
Why?
|
| Pregnant Women | 1 | 2022 | 561 | 0.560 |
Why?
|
| Bisacodyl | 1 | 2016 | 12 | 0.560 |
Why?
|
| Receptors, Opioid, mu | 1 | 2018 | 167 | 0.550 |
Why?
|
| Deglutition Disorders | 2 | 2023 | 627 | 0.540 |
Why?
|
| Endometriosis | 1 | 2023 | 869 | 0.470 |
Why?
|
| Running | 1 | 2019 | 486 | 0.470 |
Why?
|
| Dietary Fiber | 2 | 2017 | 759 | 0.430 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 585 | 0.420 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 3792 | 0.400 |
Why?
|
| Chronic Disease | 10 | 2024 | 9309 | 0.360 |
Why?
|
| Mentha piperita | 4 | 2022 | 17 | 0.340 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 1277 | 0.330 |
Why?
|
| Humans | 73 | 2024 | 760437 | 0.310 |
Why?
|
| Prevalence | 8 | 2024 | 15698 | 0.310 |
Why?
|
| Gastrointestinal Motility | 2 | 2022 | 234 | 0.290 |
Why?
|
| Gastroenterology | 3 | 2023 | 577 | 0.290 |
Why?
|
| Quality of Life | 9 | 2024 | 13338 | 0.290 |
Why?
|
| Nutrition Surveys | 6 | 2019 | 1726 | 0.280 |
Why?
|
| Depressive Disorder | 2 | 2019 | 3728 | 0.280 |
Why?
|
| Fecal Incontinence | 2 | 2020 | 241 | 0.280 |
Why?
|
| Peptides | 1 | 2019 | 4338 | 0.280 |
Why?
|
| Anal Canal | 2 | 2020 | 373 | 0.260 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3183 | 0.250 |
Why?
|
| Adult | 36 | 2024 | 220781 | 0.240 |
Why?
|
| Double-Blind Method | 8 | 2022 | 12320 | 0.240 |
Why?
|
| Swallows | 1 | 2023 | 4 | 0.230 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6894 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2022 | 10180 | 0.220 |
Why?
|
| Rectum | 2 | 2020 | 892 | 0.220 |
Why?
|
| Female | 39 | 2024 | 391875 | 0.210 |
Why?
|
| Esophageal Motility Disorders | 1 | 2023 | 49 | 0.210 |
Why?
|
| Breath Tests | 2 | 2022 | 296 | 0.200 |
Why?
|
| Eructation | 1 | 2022 | 6 | 0.200 |
Why?
|
| Middle Aged | 29 | 2024 | 220382 | 0.200 |
Why?
|
| Gastrointestinal Tract | 2 | 2018 | 831 | 0.200 |
Why?
|
| Emergency Service, Hospital | 5 | 2019 | 7860 | 0.190 |
Why?
|
| Male | 35 | 2024 | 360035 | 0.180 |
Why?
|
| Monosaccharides | 1 | 2021 | 68 | 0.180 |
Why?
|
| United States | 15 | 2024 | 72202 | 0.180 |
Why?
|
| Fermentation | 1 | 2021 | 147 | 0.180 |
Why?
|
| Disaccharides | 1 | 2021 | 170 | 0.180 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2020 | 50 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 376 | 0.170 |
Why?
|
| Young Adult | 13 | 2024 | 59068 | 0.160 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 385 | 0.160 |
Why?
|
| Flatulence | 3 | 2023 | 19 | 0.160 |
Why?
|
| Fecal Impaction | 1 | 2018 | 32 | 0.160 |
Why?
|
| Aged | 17 | 2024 | 168840 | 0.160 |
Why?
|
| Teaching Rounds | 1 | 2023 | 275 | 0.160 |
Why?
|
| Manometry | 4 | 2023 | 454 | 0.160 |
Why?
|
| Anxiety | 4 | 2022 | 4558 | 0.160 |
Why?
|
| Oligosaccharides | 1 | 2021 | 406 | 0.160 |
Why?
|
| Brain | 2 | 2022 | 27060 | 0.160 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 262 | 0.150 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2019 | 857 | 0.150 |
Why?
|
| Colonic Polyps | 1 | 2022 | 552 | 0.150 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 249 | 0.140 |
Why?
|
| Patients | 1 | 2024 | 905 | 0.140 |
Why?
|
| Picolines | 1 | 2016 | 10 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2023 | 871 | 0.140 |
Why?
|
| Gastric Emptying | 1 | 2019 | 242 | 0.140 |
Why?
|
| Citrates | 1 | 2016 | 135 | 0.140 |
Why?
|
| Loperamide | 1 | 2015 | 9 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2022 | 64591 | 0.130 |
Why?
|
| Rifamycins | 1 | 2015 | 26 | 0.130 |
Why?
|
| Benzofurans | 1 | 2016 | 139 | 0.130 |
Why?
|
| Ear Diseases | 1 | 2017 | 180 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 1077 | 0.130 |
Why?
|
| Nausea | 1 | 2018 | 679 | 0.130 |
Why?
|
| Cyclopropanes | 1 | 2017 | 432 | 0.130 |
Why?
|
| Pancreatitis | 1 | 2022 | 1096 | 0.130 |
Why?
|
| Receptors, Opioid | 1 | 2015 | 145 | 0.120 |
Why?
|
| Mouth Diseases | 1 | 2017 | 242 | 0.120 |
Why?
|
| Cost of Illness | 3 | 2019 | 1931 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2022 | 1172 | 0.120 |
Why?
|
| Feces | 2 | 2022 | 1494 | 0.120 |
Why?
|
| Headache | 1 | 2022 | 1252 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12127 | 0.120 |
Why?
|
| Protein Precursors | 1 | 2019 | 1134 | 0.120 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 411 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 816 | 0.120 |
Why?
|
| Androgens | 1 | 2022 | 1282 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2020 | 873 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2015 | 366 | 0.110 |
Why?
|
| Colon | 1 | 2022 | 1791 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2022 | 1406 | 0.110 |
Why?
|
| Placebos | 1 | 2018 | 1661 | 0.110 |
Why?
|
| Carbolines | 1 | 2015 | 294 | 0.110 |
Why?
|
| Patient Admission | 2 | 2018 | 1367 | 0.110 |
Why?
|
| Drug Costs | 1 | 2021 | 1179 | 0.110 |
Why?
|
| Aged, 80 and over | 8 | 2024 | 58859 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 2419 | 0.110 |
Why?
|
| Diet | 3 | 2021 | 8058 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2016 | 649 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2024 | 2771 | 0.100 |
Why?
|
| Adenoma | 1 | 2022 | 2157 | 0.100 |
Why?
|
| Eye Diseases | 1 | 2017 | 655 | 0.100 |
Why?
|
| Recurrence | 2 | 2024 | 8466 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4849 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2022 | 8611 | 0.100 |
Why?
|
| Sex Factors | 4 | 2019 | 10538 | 0.100 |
Why?
|
| Perception | 1 | 2018 | 1196 | 0.090 |
Why?
|
| Hospitalization | 3 | 2020 | 10698 | 0.090 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1081 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 2420 | 0.090 |
Why?
|
| Imidazoles | 1 | 2015 | 1179 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2019 | 3546 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2019 | 2975 | 0.080 |
Why?
|
| Adolescent | 6 | 2024 | 88196 | 0.080 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 26063 | 0.070 |
Why?
|
| Pain | 1 | 2023 | 5075 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3190 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7424 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22097 | 0.070 |
Why?
|
| Depression | 3 | 2021 | 8104 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2019 | 41366 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2016 | 2633 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2019 | 4936 | 0.060 |
Why?
|
| Age Factors | 2 | 2019 | 18379 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 3 | 2023 | 5491 | 0.060 |
Why?
|
| Colonoscopy | 2 | 2023 | 1392 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 5359 | 0.060 |
Why?
|
| Rome | 1 | 2023 | 28 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2022 | 15820 | 0.050 |
Why?
|
| Heartburn | 1 | 2023 | 68 | 0.050 |
Why?
|
| Pancreatic Hormones | 1 | 2022 | 12 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 29831 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2018 | 2281 | 0.050 |
Why?
|
| Parasympatholytics | 1 | 2022 | 89 | 0.050 |
Why?
|
| Age Distribution | 2 | 2018 | 2878 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 23953 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2023 | 54339 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 14002 | 0.050 |
Why?
|
| Metronidazole | 1 | 2022 | 232 | 0.040 |
Why?
|
| Length of Stay | 3 | 2019 | 6413 | 0.040 |
Why?
|
| Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
| Obesity | 2 | 2019 | 12918 | 0.040 |
Why?
|
| Educational Status | 2 | 2018 | 2518 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 312 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39078 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2023 | 3457 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 538 | 0.040 |
Why?
|
| Sick Leave | 1 | 2019 | 105 | 0.040 |
Why?
|
| Catastrophization | 1 | 2022 | 348 | 0.040 |
Why?
|
| Sensation | 1 | 2020 | 337 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2019 | 7948 | 0.040 |
Why?
|
| Haptoglobins | 1 | 2019 | 167 | 0.040 |
Why?
|
| Risk Factors | 3 | 2020 | 74055 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2022 | 756 | 0.040 |
Why?
|
| Stomach | 1 | 2022 | 694 | 0.040 |
Why?
|
| Life Style | 2 | 2019 | 3909 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 296 | 0.030 |
Why?
|
| Permeability | 1 | 2019 | 721 | 0.030 |
Why?
|
| Efficiency | 1 | 2019 | 476 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 642 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
| Demography | 1 | 2019 | 1648 | 0.030 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 3344 | 0.030 |
Why?
|
| Patient Preference | 1 | 2021 | 924 | 0.030 |
Why?
|
| Time Factors | 3 | 2022 | 39947 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1750 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 891 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1977 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2023 | 80430 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 573 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1438 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2017 | 948 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2217 | 0.020 |
Why?
|
| Reference Values | 1 | 2017 | 4921 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 8522 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2683 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5236 | 0.020 |
Why?
|
| Income | 1 | 2017 | 1874 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2412 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2568 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3026 | 0.020 |
Why?
|
| Mortality | 1 | 2018 | 2897 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 2572 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 1922 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9326 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2018 | 2278 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10494 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2017 | 5283 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2019 | 12932 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6168 | 0.010 |
Why?
|
| Animals | 2 | 2023 | 168253 | 0.010 |
Why?
|
| Child | 2 | 2018 | 80086 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20551 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 36183 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42209 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81402 | 0.010 |
Why?
|
| Age of Onset | 1 | 1997 | 3302 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1997 | 10075 | 0.000 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_